dbSNP reports that this variant has 5% allele frequency in a 120 chromosome low-coverage CEU panel (1000 genomes) and 2.6% in a mixed panel of Caucasian & African American samples. Lorenz-Depiereux et al. point to this as suggesting that the variant is a non-pathogenic polymorphism.
http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=28933977
The predicted incidence of homozygotes (1 in 400) vs. the incidence of the disease (quite rare) implies that this variant is not causal.